MedPath

WEST PENN ALLEGHENY HEALTH SYSTEM

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

19

Active:0
Completed:13

Trial Phases

3 Phases

Early Phase 1:1
Phase 4:6
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 4
6 (75.0%)
Early Phase 1
1 (12.5%)
Not Applicable
1 (12.5%)

The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling

Phase 4
Recruiting
Conditions
Stress Urinary Incontinence
Interventions
First Posted Date
2019-04-12
Last Posted Date
2024-02-06
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
150
Registration Number
NCT03913845
Locations
🇺🇸

AHN Bethel Park Health + Wellness Pavilion, Bethel Park, Pennsylvania, United States

🇺🇸

AHN Jefferson Hospital, Jefferson Hills, Pennsylvania, United States

🇺🇸

AHN West Penn Hospital, Pittsburgh, Pennsylvania, United States

and more 1 locations

T-helper 2 (Th2) Cytokine Responses in Overweight/Obese Subjects

Completed
Conditions
Obesity
Overweight
First Posted Date
2014-03-13
Last Posted Date
2014-03-13
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
46
Registration Number
NCT02085759
Locations
🇺🇸

Allegheny General Hospital, Dept. of Allergy, Asthma, & Immunology, Pittsburgh, Pennsylvania, United States

Comparing Sedara to Butorphanol in Early Labor

Not Applicable
Withdrawn
Conditions
Labor Pain
Interventions
Drug: 50% Nitrous Oxide/50% Oxygen
First Posted Date
2012-07-10
Last Posted Date
2020-10-05
Lead Sponsor
West Penn Allegheny Health System
Registration Number
NCT01636999
Locations
🇺🇸

West Penn Hospital, Pittsburgh, Pennsylvania, United States

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Phase 4
Completed
Conditions
Asthma
Allergic Rhinitis
Interventions
Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo
Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase
Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo
Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris
Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase
Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
First Posted Date
2012-03-12
Last Posted Date
2020-11-04
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
22
Registration Number
NCT01550471
Locations
🇺🇸

Pediatric Alliance-Greentree Division, Green Tree, Pennsylvania, United States

🇺🇸

Alleghney General Hospital, Pittsburgh, Pennsylvania, United States

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Beclomethasone, Budesonide, Fluticasone
Drug: Budesonide, Fluticasone, Beclomethasone
Drug: Fluticasone, Budesonide, Beclomethasone
Drug: Budesonide, Beclomethasone, Fluticasone
First Posted Date
2012-01-30
Last Posted Date
2020-11-18
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
32
Registration Number
NCT01520688
Locations
🇺🇸

Pediatric Alliance-Greentree Division, Green Tree, Pennsylvania, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.